Skip navigation

Roche sales down 9 percent in first quarter

Swiss drug maker Roche Holding AG blamed the strength of the franc Thursday for a 9 percent year-on-year drop in first quarter sales, but also felt the impact of regulatory concerns over its Avastin cancer medicine and an expected drop in Tamiflu orders.Full story

Making money off the outbreak? It’s possible

The outbreak of the H1N1 influenza has major political and public-health ramifications, but it's also causing agita for the business sector. Full story

Roche controls 96.2 percent of Genentech as bid closes

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG <ROG.VX> said on Thursday it controlled a total of 96.2 percent of Genentech <DNA.N> shares after completing its tender offer for the 44 percent stake it did not already own. Full story

Sponsored Links

Articles

Roche to take over Genentech for $47 billion

advertisement | ad info

Related Photos

FILE - In this April 28, 2009 file photo packages of the medicine Tamiflu by Swiss pharmaceutical company Roche are seen in Stuttgart, southern Germany. Swiss pharmaceuticals maker Roche Holding AG said Thursday Oct 15, 2009 its third-quarter sales rose 14 percent to 12.4 billion Swiss francs (US$